Understanding and treating Myotonic Dystrophy Type 2 (DM2)
DM2 pathomechansims and therapeutic development
Researchers are creating new mouse models and testing potential therapies aimed at adults with Myotonic Dystrophy Type 2 (DM2).
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11161621 on NIH RePORTER |
What this research studies
This project focuses on the causes and treatment of DM2 by studying the toxic repeat RNAs made from the CNBP gene and how they disrupt normal RNA processing. The team has created new DM2 mouse models, including a human CNBP BAC transgenic line and an intensive HSA-DM2 line, to reproduce the human disease. These mice will be used to study disease mechanisms such as RAN translation and altered splicing and to test candidate therapeutic approaches developed for repeat expansion disorders. Work is lab-based at the University of Florida with the goal of moving promising leads toward therapies for people with DM2.
Who could benefit from this research
Good fit: Adults (21+) with genetically confirmed DM2 would be the ideal candidates for future patient-facing studies, sample donations, or clinical trials stemming from this work.
Not a fit: People without CNBP/CCTG repeat expansions, children under 21, or patients with other unrelated neuromuscular diseases are unlikely to benefit directly from this specific project.
Why it matters
Potential benefit: If successful, this work could lead to treatments that reduce muscle problems and other symptoms of DM2 and enable future clinical trials for people with the condition.
How similar studies have performed: Related work in DM1 has shown promising results in animal models and early clinical efforts, but DM2-specific models and treatments are newer and less tested.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Swanson, Maurice Scott — University of Florida
- Study coordinator: Swanson, Maurice Scott
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.